Hembre B, Chokshi M, Hoffman S, Suleman F, Andresen S, Sandberg K
Global Health. 2025; 21(1):3.
PMID: 39893431
PMC: 11787748.
DOI: 10.1186/s12992-024-01092-2.
Puri M, Veillard J, Brown A, Klein D
BMJ Glob Health. 2024; 9(11).
PMID: 39521454
PMC: 11551981.
DOI: 10.1136/bmjgh-2024-015136.
Santangelo O, Provenzano S, Di Martino G, Ferrara P
Vaccines (Basel). 2024; 12(8).
PMID: 39204011
PMC: 11360777.
DOI: 10.3390/vaccines12080885.
Prem K, Cernuschi T, Malvolti S, Brisson M, Jit M
EClinicalMedicine. 2024; 74:102735.
PMID: 39091671
PMC: 11293525.
DOI: 10.1016/j.eclinm.2024.102735.
Du Z, Liu C, Bai Y, Wang L, Lim W, Lau E
JMIR Public Health Surveill. 2024; 10:e49812.
PMID: 39012087
PMC: 11259582.
DOI: 10.2196/49812.
Enabling product development partnerships to bring forward the next generation of health technologies.
So A, Woo J, Helble M
Health Aff Sch. 2024; 2(1):qxad088.
PMID: 38770112
PMC: 11103732.
DOI: 10.1093/haschl/qxad088.
Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
Ruiz A, Bezruki A, Shinabargar E, Large K, Vieira M, Slovenski I
Global Health. 2024; 20(1):25.
PMID: 38532484
PMC: 10964709.
DOI: 10.1186/s12992-024-01017-z.
Mechanism design for a fair and equitable approach to global vaccine distribution: The case of COVID-19.
Abedrabboh K, Al-Majid L, Al-Fagih Z, Al-Fagih L
PLOS Glob Public Health. 2023; 3(12):e0001711.
PMID: 38153908
PMC: 10754452.
DOI: 10.1371/journal.pgph.0001711.
Lessons learned from the Global Polio Eradication Initiative: A roadmap for the international COVID-19 vaccination campaign.
Belshe W, Alswang J, Uplift-Brown A, Chilenga L, Chipolombwe J, Seaman V
Malawi Med J. 2023; 34(4):294-298.
PMID: 38125783
PMC: 10645833.
DOI: 10.4314/mmj.v34i4.12.
Global regulatory reforms to promote equitable vaccine access in the next pandemic.
Mahoney R, Hotez P, Bottazzi M
PLOS Glob Public Health. 2023; 3(10):e0002482.
PMID: 37851688
PMC: 10584090.
DOI: 10.1371/journal.pgph.0002482.
A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review.
Pushkaran A, Chattu V, Narayanan P
BMJ Glob Health. 2023; 8(10).
PMID: 37793808
PMC: 10551961.
DOI: 10.1136/bmjgh-2023-012168.
Increasing Equity in the Transnational Allocation of Vaccines Against Emerging Pathogens: A Multi-Modal Approach.
Rutschman A
J Law Med Ethics. 2023; 51(2):247-257.
PMID: 37655573
PMC: 10881268.
DOI: 10.1017/jme.2023.63.
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Partnerships of Equitable Vaccine Access.
Halabi S, Gostin L, Aneja K, Nardi F, Gottschalk K, Monahan J
J Law Med Ethics. 2023; 51(2):234-246.
PMID: 37655558
PMC: 10881267.
DOI: 10.1017/jme.2023.85.
Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.
Eren Vural I, Herder M, Doll A, Graham J
Int J Health Policy Manag. 2023; 12:6936.
PMID: 37579382
PMC: 10462233.
DOI: 10.34172/ijhpm.2023.6936.
The role of National Immunization Technical Advisory Groups in advising COVID-19 immunization policy during the pandemic: lessons from the Federation of Bosnia and Herzegovina.
Musa S, Jacques-Carroll L, Palo M
Front Public Health. 2023; 11:1193281.
PMID: 37457274
PMC: 10348889.
DOI: 10.3389/fpubh.2023.1193281.
Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rate.
Aksentijevic D, Tanner R, Lazovic-Pita L, Pestek A, Abdic A
J Infect Public Health. 2023; 16(8):1322-1331.
PMID: 37343504
PMC: 10239289.
DOI: 10.1016/j.jiph.2023.06.001.
Factors, enablers and challenges for COVID-19 vaccine development.
Excler J, Saville M, Privor-Dumm L, Gilbert S, Hotez P, Thompson D
BMJ Glob Health. 2023; 8(6).
PMID: 37277195
PMC: 10255030.
DOI: 10.1136/bmjgh-2023-011879.
The Global Health Architecture: Governance and International Institutions to Advance Population Health Worldwide.
Gostin L, Friedman E, Finch A
Milbank Q. 2023; 101(S1):734-769.
PMID: 37096621
PMC: 10126971.
DOI: 10.1111/1468-0009.12627.
Rethinking solidarity towards equity in global health: African views.
Atuire C, Hassoun N
Int J Equity Health. 2023; 22(1):52.
PMID: 36964530
PMC: 10038363.
DOI: 10.1186/s12939-023-01830-9.
Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
Rando H, Lordan R, Lee A, Naik A, Wellhausen N, Sell E
mSystems. 2023; 8(2):e0092722.
PMID: 36861991
PMC: 10134813.
DOI: 10.1128/msystems.00927-22.
